These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 6330852

  • 1. Genetic characterization of poliovirus isolates in Canada, 1962-1981.
    Furesz J, Armstrong RE, Contreras G, Wachmann B.
    Rev Infect Dis; 1984; 6 Suppl 2():S528-34. PubMed ID: 6330852
    [Abstract] [Full Text] [Related]

  • 2. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B, Henning D, Armstrong R, Boucher DW, Contreras G, Furesz J.
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [Abstract] [Full Text] [Related]

  • 3. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S.
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Properties of poliovirus strains isolated from waste waters of nurseries in Prague in 1969-1982.
    Matyásová I, Koza J.
    J Hyg Epidemiol Microbiol Immunol; 1985 Nov; 29(4):387-98. PubMed ID: 3003187
    [Abstract] [Full Text] [Related]

  • 6. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM, Manor Y, Sofer D, Swartz T, Mendelson E.
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Properties of poliovirus strains isolated over the period 1969-1978 from the main municipal sewerage system of the city of Prague.
    Matyásová I, Koza J.
    J Hyg Epidemiol Microbiol Immunol; 1982 May; 26(2):162-75. PubMed ID: 6288797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Investigations of clinical isolations of oral poliovirus vaccine strains between 2000 and 2005 in southern Taiwan.
    Chi CY, Tseng FC, Liu DP, Chang YW, Wu HC, Huang YF, Hwang KP, Hsu YW, Wang SM, Liu CC, Wu HS, Yang JY, Yang CF, Wang JR, Su IJ.
    J Clin Virol; 2009 Jun; 45(2):129-34. PubMed ID: 19394265
    [Abstract] [Full Text] [Related]

  • 13. WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.
    Ferguson M, Magrath DI, Minor PD, Schild GC.
    Bull World Health Organ; 1986 Jun; 64(2):239-46. PubMed ID: 3017595
    [Abstract] [Full Text] [Related]

  • 14. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
    Payment P, Trudel M, Thibodeau L, Lecomte J.
    Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
    [Abstract] [Full Text] [Related]

  • 15. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M, Nakayama T, Matsuura K, Hasegawa S, Ando S, Obara M, Nagai Y, Yoshida H, Horie H.
    Acta Virol; 2006 May; 50(2):139-43. PubMed ID: 16808333
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN, Van Zyl WB, Van Heerden J, Kruger M, Blignaut L, Grabow WO, Ehlers MM.
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.